Optinose (OPTN) has announced the appointment of Terry Kohler as its new Chief Financial Officer. Kohler brings a wealth of experience to the role, having most recently served as the Chief Financial Officer for Verrica Pharmaceuticals. With over two decades in the biotech finance sector, Kohler has established himself as a seasoned leader.
Before his tenure at Verrica Pharmaceuticals, Kohler held significant positions at Endo International PLC, including Vice President of Corporate Development and Treasurer, as well as Vice President of U.S. Branded and Specialty Pharmaceuticals. His career also includes completing the Johnson & Johnson MBA Leadership Development program and gaining valuable experience in various investment banking firms.